It is this unique combination of experiences that makes his evaluation of the biotech field so compelling. Biotech Insight provides insightful discussion of competing technologies and future advances. Questions such as the importance of a new technology and how will it be accepted by practicing doctors are addressed with skills that few analysts possess. Garren's experience and expertise enables him to present a valuable perspective to individuals interested in investing in biotech. To begin receiving of Biotech Insight, just click here and in the new browser window select the subscribe button on the left and then go to the bottom of the page and fill out the subscription form.
Biotech stocks are inherently risky.
The opinions expressed in this newsletter are that of the publisher and do not represent a recommendation to buy or sell. The publisher and its associates or employees may have positions in, and from time to time may buy or sell stock mentioned herein. The content of the newsletter reflects information gathered from reliable sources but the accuracy and completeness cannot be guaranteed. All Rights Reserved. No portion of this letter may be reproduced without the written consent of Garren publishing.